Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine infusion for ERCP sedation
NCT03996577Phase 4Unknown
- Sponsor
- Shandong University
- Start
- May 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine (2 arms), sponsored by Shandong University. Primary endpoint: Propofol consumption difference between the two groups. Status: unknown.
02
Drugs
lidocaine
Beyond the preview
Go deeper on NCT03996577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03996577.